Wednesday, October 28, 2026
Data from SEC filings, checked daily
Public filings, plainly told
WallStPal · PDF guide
ORKA Insider Trading: Insider Buys and Sells · https://wallstpal.com/stock/orka/insider-trading/ · saved 2026-10-28

About this page

Insider trades reported on SEC Form 4: when the people who run a company buy or sell its shares with their own money.

How to read it

Form 4
The form a company insider (officer, director or owner of more than 10%) must file with the SEC within two business days of buying or selling the company's shares.
Buy (P) and Sell (S)
Open-market purchases and sales. Gifts, option exercises and automatic tax withholding are left out because they say little about what the insider thinks.
Value
Shares times price, as reported on the filing.
10b5-1
A trade made under a plan set up in advance. Planned sales are common and usually say less than an unplanned purchase.
Late filing
A Form 4 filed more than two business days after the trade.
Vs. S&P 500
How the stock did after the trade minus how the overall market did in the same weeks.

A real example

In January 2016, when bank stocks were falling, JPMorgan Chase CEO Jamie Dimon bought 500,000 JPMorgan shares with his own money, worth about $26 million. His Form 4 made the purchase public within days, and investors read it as a strong sign of confidence.

Explain it like I'm 13

If the coach of a team bets his own allowance that his team will win, that tells you something. A Form 4 is the note a company boss must hand in whenever he buys or sells his own company's shares, so everyone can see it.

Data from public SEC filings and congressional reports. Information, not investment advice. Check every number against the filing linked on the page.

Summarize with AIChatGPTClaudePerplexityGoogle AIGrokCopilot
Insider tradingForm 4

Oruka Therapeutics, Inc. (ORKA) Insider Trading

28 open-market trades reported since Jun 15, 2026: 0 purchases worth $0 and 28 sales worth $325.5M.

By insider

InsiderRoleBuysBoughtSellsSoldLatest
Paul T. QuinlanGeneral Counsel0$05$7.44MOct 20, 2026
Joana GoncalvesChief Medical Officer0$05$3.20MOct 15, 2026
Arjun AgarwalPresident0$09$4.51MOct 13, 2026
Lawrence Otto KleinCEO0$04$9.33MOct 2, 2026
Laura Lee SandlerCOO0$04$1.06MSep 15, 2026
Fairmount Funds Management LLCDirector0$01$300.0MJul 1, 2026

All trades

ORKA insider trades
FiledTradedInsiderRoleTypeSharesPrice ($)ValueHolding3 mo. afterFiling
Oct 20Oct 20Paul T. QuinlanGeneral CounselGeneral Counsel▼ SELL10b5-19,00078.53$707K−23%Form 4 ↗
Oct 15Oct 15Joana GoncalvesChief Medical OfficerChief Medical Officer▼ SELL10b5-17,00074.81$524K−18%Form 4 ↗
Oct 13Oct 12Arjun AgarwalPresidentPresident▼ SELL10b5-19,99980.60$806K−41%Form 4 ↗
Oct 2Oct 1Lawrence Otto KleinCEOCEO▼ SELL10b5-125,00083.62$2.09M−2.6%Form 4 ↗
Sep 21Sep 21Paul T. QuinlanGeneral CounselGeneral Counsel▼ SELL10b5-110,00093.64$936K−25%Form 4 ↗
Sep 21Sep 21Arjun AgarwalPresidentPresident▼ SELL10b5-153395.75$51K−3.6%Form 4 ↗
Sep 15Sep 11Arjun AgarwalPresidentPresident▼ SELL10b5-19,45992.23$872K−38%Form 4 ↗
Sep 15Sep 15Joana GoncalvesChief Medical OfficerChief Medical Officer▼ SELL10b5-17,94792.38$734K−20%Form 4 ↗
Sep 15Sep 15Lawrence Otto KleinCEOCEO▼ SELL2,45295.71$235K−0.3%Form 4 ↗
Sep 15Sep 15Paul T. QuinlanGeneral CounselGeneral Counsel▼ SELL1,03995.71$99K−3.3%Form 4 ↗
Sep 15Sep 15Laura Lee SandlerCOOCOO▼ SELL90695.71$87K−0.4%Form 4 ↗
Sep 15Sep 15Arjun AgarwalPresidentPresident▼ SELL10b5-156095.71$54K−3.7%Form 4 ↗
Sep 1Sep 1Lawrence Otto KleinCEOCEO▼ SELL10b5-175,00091.83$6.89M−7.5%Form 4 ↗
Sep 1Sep 1Laura Lee SandlerCOOCOO▼ SELL10b5-15,00091.82$459K−2.1%Form 4 ↗
Aug 17Aug 17Joana GoncalvesChief Medical OfficerChief Medical Officer▼ SELL10b5-17,000111.84$783K−18%Form 4 ↗
Aug 14Aug 14Paul T. QuinlanGeneral CounselGeneral Counsel▼ SELL10b5-152,000108.49$5.64M−63%Form 4 ↗
Aug 14Aug 13Arjun AgarwalPresidentPresident▼ SELL10b5-110,000106.66$1.07M−40%Form 4 ↗
Jul 15Jul 15Joana GoncalvesChief Medical OfficerChief Medical Officer▼ SELL10b5-17,00086.28$604K−18%Form 4 ↗
Jul 13Jul 13Arjun AgarwalPresidentPresident▼ SELL10b5-19,99984.63$846K−40%Form 4 ↗
Jul 1Jul 1Fairmount Funds Management LLCDirectorDirector (ind.)▼ SELL3,553,41084.43$300.0M−76%Form 4 ↗
Jul 1Jul 1Laura Lee SandlerCOOCOO▼ SELL10b5-15,00094.42$472K−2.1%Form 4 ↗
Jun 22Jun 22Arjun AgarwalPresidentPresident▼ SELL10b5-11,58780.95$128K−9.4%Form 4 ↗
Jun 15Jun 12Arjun AgarwalPresidentPresident▼ SELL10b5-19,45969.72$660K−35%Form 4 ↗
Jun 15Jun 15Joana GoncalvesChief Medical OfficerChief Medical Officer▼ SELL10b5-17,94769.28$551K−20%Form 4 ↗
Jun 15Jun 15Lawrence Otto KleinCEOCEO▼ SELL1,72969.69$120K−0.2%Form 4 ↗
Jun 15Jun 15Paul T. QuinlanGeneral CounselGeneral Counsel▼ SELL73369.69$51K−2.3%Form 4 ↗
Jun 15Jun 15Laura Lee SandlerCOOCOO▼ SELL60069.69$42K−0.3%Form 4 ↗
Jun 15Jun 15Arjun AgarwalPresidentPresident▼ SELL10b5-139569.69$28K−2.3%Form 4 ↗
Source: SEC Form 4 filings, retrieved Oct 28, 2026. How we read filings